Cargando…

Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury

Schisandra chinensis (SC) is a well-known important traditional Chinese medicine (TCM) that has been used to treat liver disease in China for a long time. However, its overall effects and mechanism of action are unclear. The present study aimed to explore the potential mechanism of SC in protection...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Lianlin, Mao, Jing, Hao, Min, Lu, Tulin, Mao, Chunqin, Ji, De, Tong, Huangjin, Fei, Chenghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975200/
https://www.ncbi.nlm.nih.gov/pubmed/32009955
http://dx.doi.org/10.3389/fphar.2019.01543
_version_ 1783490251446026240
author Su, Lianlin
Mao, Jing
Hao, Min
Lu, Tulin
Mao, Chunqin
Ji, De
Tong, Huangjin
Fei, Chenghao
author_facet Su, Lianlin
Mao, Jing
Hao, Min
Lu, Tulin
Mao, Chunqin
Ji, De
Tong, Huangjin
Fei, Chenghao
author_sort Su, Lianlin
collection PubMed
description Schisandra chinensis (SC) is a well-known important traditional Chinese medicine (TCM) that has been used to treat liver disease in China for a long time. However, its overall effects and mechanism of action are unclear. The present study aimed to explore the potential mechanism of SC in protection against alcoholic liver injury (ALI). In this research, to enable a full assessment of metabolic changes in ALI in Sprague-Dawley rats and to increase our understanding of physiological changes in normal and pathological states, ultra-high performance liquid chromatography combined with quadrupole time of flight mass spectrometry (UHPLC-Q/TOF-MS) was used to probe potential biomarkers to learn more about ALI and to evaluate the overall effect of SC for ALI in rats. Principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) were used to investigate global metabolomic alterations and to evaluate the therapeutic effects of SC in rats. The component–target–pathway network of SC was then constructed on the basis of the network pharmacology, and the liver injury-relevant signaling pathways were thus dissected and validated. The results showed that SC has conspicuous therapeutic efficacy for ALI, as suggested by the results of the pathological section and biochemical index assays, such as those for Alanine aminotransferase (ALT), Aspartate transaminase (AST), Alkaline phosphatase (AKP), γ-glutamyl transferase (γ-GT/GGT), Reactive oxygen species (ROS), and Malondialdehyde (MDA). Furthermore, 21 kinds of potential biomarkers were identified in plasma samples of ALI rats, and 20 kinds of potential biomarkers were identified in their bile samples. The biomarkers were mainly related to inflammation and dysfunctions of amino acids and energy metabolism. The recovery of these dysfunctions partly led to the curative effect of SC on ALI.
format Online
Article
Text
id pubmed-6975200
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69752002020-01-31 Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury Su, Lianlin Mao, Jing Hao, Min Lu, Tulin Mao, Chunqin Ji, De Tong, Huangjin Fei, Chenghao Front Pharmacol Pharmacology Schisandra chinensis (SC) is a well-known important traditional Chinese medicine (TCM) that has been used to treat liver disease in China for a long time. However, its overall effects and mechanism of action are unclear. The present study aimed to explore the potential mechanism of SC in protection against alcoholic liver injury (ALI). In this research, to enable a full assessment of metabolic changes in ALI in Sprague-Dawley rats and to increase our understanding of physiological changes in normal and pathological states, ultra-high performance liquid chromatography combined with quadrupole time of flight mass spectrometry (UHPLC-Q/TOF-MS) was used to probe potential biomarkers to learn more about ALI and to evaluate the overall effect of SC for ALI in rats. Principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) were used to investigate global metabolomic alterations and to evaluate the therapeutic effects of SC in rats. The component–target–pathway network of SC was then constructed on the basis of the network pharmacology, and the liver injury-relevant signaling pathways were thus dissected and validated. The results showed that SC has conspicuous therapeutic efficacy for ALI, as suggested by the results of the pathological section and biochemical index assays, such as those for Alanine aminotransferase (ALT), Aspartate transaminase (AST), Alkaline phosphatase (AKP), γ-glutamyl transferase (γ-GT/GGT), Reactive oxygen species (ROS), and Malondialdehyde (MDA). Furthermore, 21 kinds of potential biomarkers were identified in plasma samples of ALI rats, and 20 kinds of potential biomarkers were identified in their bile samples. The biomarkers were mainly related to inflammation and dysfunctions of amino acids and energy metabolism. The recovery of these dysfunctions partly led to the curative effect of SC on ALI. Frontiers Media S.A. 2020-01-16 /pmc/articles/PMC6975200/ /pubmed/32009955 http://dx.doi.org/10.3389/fphar.2019.01543 Text en Copyright © 2020 Su, Mao, Hao, Lu, Mao, Ji, Tong and Fei http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Su, Lianlin
Mao, Jing
Hao, Min
Lu, Tulin
Mao, Chunqin
Ji, De
Tong, Huangjin
Fei, Chenghao
Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury
title Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury
title_full Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury
title_fullStr Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury
title_full_unstemmed Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury
title_short Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury
title_sort integrated plasma and bile metabolomics based on an uhplc-q/tof-ms and network pharmacology approach to explore the potential mechanism of schisandra chinensis-protection from acute alcoholic liver injury
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975200/
https://www.ncbi.nlm.nih.gov/pubmed/32009955
http://dx.doi.org/10.3389/fphar.2019.01543
work_keys_str_mv AT sulianlin integratedplasmaandbilemetabolomicsbasedonanuhplcqtofmsandnetworkpharmacologyapproachtoexplorethepotentialmechanismofschisandrachinensisprotectionfromacutealcoholicliverinjury
AT maojing integratedplasmaandbilemetabolomicsbasedonanuhplcqtofmsandnetworkpharmacologyapproachtoexplorethepotentialmechanismofschisandrachinensisprotectionfromacutealcoholicliverinjury
AT haomin integratedplasmaandbilemetabolomicsbasedonanuhplcqtofmsandnetworkpharmacologyapproachtoexplorethepotentialmechanismofschisandrachinensisprotectionfromacutealcoholicliverinjury
AT lutulin integratedplasmaandbilemetabolomicsbasedonanuhplcqtofmsandnetworkpharmacologyapproachtoexplorethepotentialmechanismofschisandrachinensisprotectionfromacutealcoholicliverinjury
AT maochunqin integratedplasmaandbilemetabolomicsbasedonanuhplcqtofmsandnetworkpharmacologyapproachtoexplorethepotentialmechanismofschisandrachinensisprotectionfromacutealcoholicliverinjury
AT jide integratedplasmaandbilemetabolomicsbasedonanuhplcqtofmsandnetworkpharmacologyapproachtoexplorethepotentialmechanismofschisandrachinensisprotectionfromacutealcoholicliverinjury
AT tonghuangjin integratedplasmaandbilemetabolomicsbasedonanuhplcqtofmsandnetworkpharmacologyapproachtoexplorethepotentialmechanismofschisandrachinensisprotectionfromacutealcoholicliverinjury
AT feichenghao integratedplasmaandbilemetabolomicsbasedonanuhplcqtofmsandnetworkpharmacologyapproachtoexplorethepotentialmechanismofschisandrachinensisprotectionfromacutealcoholicliverinjury